DE1374910U - - Google Patents

Info

Publication number
DE1374910U
DE1374910U DENDAT1374910D DE1374910DU DE1374910U DE 1374910 U DE1374910 U DE 1374910U DE NDAT1374910 D DENDAT1374910 D DE NDAT1374910D DE 1374910D U DE1374910D U DE 1374910DU DE 1374910 U DE1374910 U DE 1374910U
Authority
DE
Germany
Prior art keywords
dur
dlu
uin
dor
major
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1374910D
Other languages
German (de)
English (en)
Publication of DE1374910U publication Critical patent/DE1374910U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
DENDAT1374910D Active DE1374910U (https=)

Publications (1)

Publication Number Publication Date
DE1374910U true DE1374910U (https=)

Family

ID=687744

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1374910D Active DE1374910U (https=)

Country Status (1)

Country Link
DE (1) DE1374910U (https=)

Similar Documents

Publication Publication Date Title
ATE164064T1 (de) Zusammensetzungen, die mono oder polyhydroxylierte aminosäuren zur behandlung des insulinunabhängigen diabetes mellitus enthalten
BE1002406A5 (fr) Compositions pharmaceutiques.
FI850078L (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
US11406617B2 (en) Compounds for the treatment of bovine or swine respiratory disease
HU213474B (en) Process for production of pharmaceutical composition containing sertraline for treatment of premature ejaculation
KR101462060B1 (ko) 치환된 4-페닐테트라하이드로이소퀴놀린, 이의 제조방법,약제로서의 이의 용도 및 이를 함유하는 약제
AR004961A1 (es) Modificacion cristalina v del clorhidrato de(r)-(-)-2-{n-[4-(1,1-dioxido-3- oxo-2,3-dihidro-benzisotiazol-2-il)-butil]-aminometil)cromano, unprocedimiento para su preparacion, medicamentos que lo contienen, el uso de dicho clorhidrato para la preparacion de medicamentos, una composicion para el
DE1374910U (https=)
ATE336254T1 (de) Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
DK582588D0 (da) Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse
Hammond et al. The occurrence of a second asexual generation in the life cycle of Eimeria bovis in calves
MA27277A1 (fr) Le pentafluorosulfanyl-benzoylguanidine, methode pour sa production et son utilisation comme medicament ou agent de diagnostique et medicament le contenant
EP0314011A3 (de) Purinderivate
EP4223301A1 (en) Composition for preventing or treating periodontal diseases, comprising bacillus velezensis strain, culture medium thereof, or culture supernatant thereof as active ingredient
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
Hirsch et al. Subarachnoid hemorrhage following ephedrine and MAO inhibitor
Guarro Comments on recent human infections caused by ascomycetes
US3320252A (en) Certain cycloalkyl benzylamines
Seabury et al. Mycetoma mandibularis due to Nocardia pelletieri
WO2025046130A3 (en) T cell broad betacoronavirus vaccine
Ezeibe et al. BLOOD COAGULATION TIME AS A POSSIBLE TOOL FOR THE CLINICAL DIFFERENTIATION OF CANINE DISTEMPER AND TRYPANOSOMOSIS
DE1393369U (https=)
DE10204072A1 (de) Neue Verbindungen, die Faktor Xa-Aktivität inhibieren
ABE et al. Studies on the Preparation, Standardization and Preservation of Lepromin. III. Influence of Tissue Component on the Standardization of Lepromin.
DE685960C (de) Verfahren zur Herstellung therapeutisch wirksamer Amidine